Last reviewed · How we verify
GSK2339345
At a glance
| Generic name | GSK2339345 |
|---|---|
| Sponsor | GlaxoSmithKline |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- A Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK2339345. (PHASE1)
- The Safety, Tolerability, PK and PD of GSK2339345 in Healthy Subjects (PHASE1)
- GSK2339345 Hypertussive Challenge Study (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |